Garda Capital Partners LP Johnson & Johnson Transaction History

Garda Capital Partners LP

  • $396 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024
SELL
$145.6 - $158.88 $550,076 - $600,248
-3,778 Reduced 32.82%
7,735 $1.21 Million
Q3 2023

Nov 13, 2023
BUY
$155.75 - $174.48 $1.79 Million - $2.01 Million
11,513 New
11,513 $1.79 Million
Q1 2023

May 10, 2023
BUY
$151.05 - $180.26 $818,388 - $976,648
5,418 New
5,418 $839,000

Others Institutions Holding JNJ

# of Institutions
4,275
Shares Held
1.68B
Call Options Held
17.6M
Put Options Held
14.5M
View Full List

About JOHNSON & JOHNSON

JNJ Quotes by TradingView
  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $379B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Garda Capital Partners LP Portfolio

Follow Garda Capital Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Garda Capital Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Garda Capital Partners LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email